South Korea's Fat Faced Future: The Ozempic Effect Takes Shape The proliferation of "Ozempic face" – a gaunt, hollow eyed visage sported by devotees of semaglutide and other GLP 1 weight loss medications – has sparked fascination and horror among beauty enthusiasts worldwide.
South Korean biotech firm L&C Bio sees an opportunity in this phenomenon, betting on the next big thing in K beauty: injectable skin boosters made from donated human fat.
L&C's CEO Lee Whan Chul makes a compelling case for his company's new product, MegaAdipoECM.